PENGXIANG HUANG to Neoplasms
This is a "connection" page, showing publications PENGXIANG HUANG has written about Neoplasms.
Connection Strength
0.850
-
Metabolic alterations in cancer cells and therapeutic implications. Chin J Cancer. 2011 Aug; 30(8):508-25.
Score: 0.125
-
Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity. Cancer Biol Ther. 2011 Jan 15; 11(2):150-6.
Score: 0.121
-
Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion. 2010 Nov; 10(6):614-25.
Score: 0.117
-
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009 Jul; 8(7):579-91.
Score: 0.108
-
Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim Biophys Acta. 2009 May; 1787(5):553-60.
Score: 0.106
-
The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr. 2007 Jun; 39(3):267-74.
Score: 0.094
-
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science. 2023 09 08; 381(6662):eabn4180.
Score: 0.073
-
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
Score: 0.043
-
Small mitochondria-targeting molecules as anti-cancer agents. Mol Aspects Med. 2010 Feb; 31(1):75-92.
Score: 0.028
-
Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol. 2006 Dec 18; 175(6):913-23.
Score: 0.023
-
BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018 10; 20(10):1181-1192.
Score: 0.013